4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-056348
President and CEO gave up 6,240 shares (to pay taxes)
- President and CEO acquired 18,539 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin President and CEO | 2023-11-18 | Option exercise | +6,758 | 5,282,554 | D | ||
| Jiang Wenbin President and CEO | 2023-11-18 | Shares withheld for taxes | −2,275 | $5.98 | $13,605 | 5,280,279 | D |
| Jiang Wenbin President and CEO | 2023-11-18 | Option exercise | +11,781 | 5,292,060 | D | ||
| Jiang Wenbin President and CEO | 2023-11-18 | Shares withheld for taxes | −3,965 | $5.98 | $23,711 | 5,288,095 | D |
| Derivatives | |||||||
| Jiang Wenbin President and CEO | 2023-11-18 | Option exercise · Restricted Stock Units | −6,758 | 58,578 | D | ||
| Jiang Wenbin President and CEO | 2023-11-18 | Option exercise · Restricted Stock Units | −11,781 | 157,085 | D | ||
Loading xslF345X05/doc4.xml…